Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Is It Too Late to Buy Eli Lilly and Co (LLY) After 4.4% Rally? GF Value Says Undervalued
05:06pm, Tuesday, 12'th May 2026
On May 12, 2026, Eli Lilly and Co (LLY) shares rose 4.4% today, closing at $992.36. The stock has fluctuated within a 52-week range of $623.78 to $1133.95, refl
In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold st
Through charitable support of HATCH, United Way Worldwide, United Way of Central Indiana and the Pacers Foundation, the initiative supports efforts to expand access to protein-rich food across communi
Eli Lilly Price Prediction: This Is Where The Stock Will End This Year
11:25am, Tuesday, 12'th May 2026
Few stocks have polarized investors in 2026 like Eli Lilly (NYSE:LLY | LLY Price Prediction).
Lilly Bounces Into ‘Sell in May' Territory as Pricing Pressures Loom
07:40am, Tuesday, 12'th May 2026
The market adage “Sell in May and Go Away” rarely fits a single name cleanly.
Exclusive: Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity
03:14pm, Monday, 11'th May 2026
Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules against advertising prescription medicines to consumers even in
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale
Why Eli Lilly (LLY) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 11'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pfizer vs Eli Lilly: Different Bets on Pharma M&A
09:05am, Monday, 11'th May 2026
Pfizer (NYSE: PFE | PFE Price Prediction) and Eli Lilly (NYSE: LLY) recently reported quarterly results that read like two scripts from opposite ends of pharma.
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
08:55am, Monday, 11'th May 2026
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NY
AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth
02:30pm, Sunday, 10'th May 2026
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (
Eli Lilly: 'Strong Buy' Raised Revenue Guidance By $2 Billion For 2026 And Label Expansions
07:11am, Sunday, 10'th May 2026
Eli Lilly remains a 'strong buy' as I see robust revenue growth across obesity, diabetes, immunology, and oncology franchises. LLY's MOUNJARO and ZEPBOUND delivered Q1 2026 revenues of $8.66B [+125%]
Lilly's obesity pill tops 7,000 prescriptions in fourth week, signals modest uptake
08:58am, Friday, 08'th May 2026
Eli Lilly's new oral weight-loss drug, Foundayo, was prescribed 7,335 times in the U.S. in the fourth week, a modest uptake compared to rival Novo Nordisk's Wegovy pill, analysts said.
Eli Lilly Now Has the World's Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy?
12:42pm, Thursday, 07'th May 2026
Mounjaro generated $8.66 billion in sales in the first quarter.
Retatrutide Black Market: Why Consumers Will Do Anything To Get Eli Lilly's New GLP
12:10pm, Thursday, 07'th May 2026
Eli Lilly's next-generation weight-loss drug, Retatrutide, could hit the shelves soon. Though the treatment has yet to attain FDA approval, demand is already so heavy that consumers are going to the b
